ArticleFrontiers in cardiovascular medicine2026
Modified stepwise method with the guidance of QDOT MICRO catheter for mitral isthmus ablation in patients with persistent atrial fibrillation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06145906 (Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ethanol infusion of the vein of Marshall (EI-VOM) has elevated the success rate of mitral isthmus (MI) block in patients with persistent atrial fibrillation (PeAF). However, the procedure involve the extensive endocardial ablation and epicardial ablation, which brought the operational difficulty and risk. Material and methods: Patients with PeAF were randomly assigned in a 1:1 ratio to either STSF catheter group using the stepwise method (STSF group) or QDM catheter group using a modified stepwise method (QDM group) for MI ablation. The modified stepwise method was as follows: step 1, The potential of VOM was mapped from endocardium using the QDM catheter. Step 2, EI-VOM. Step 3, precise endocardial ablation guiding by VOM potential. Step 4, QDM catheter was cannulated into the CS for epicardial ablation, especially the ostium of Marshall. The immediate procedural results were compared between the two groups. Results: After excluding 5 patients with unsuccessful EI-VOM, 68 patients were divided into STSF group (36 cases) and QDM group (32 cases). The potential of VOM could be clearly mapped from endocardium using a QDM catheter. Both the accumulated operation time ( Conclusions: The QDM catheter can be used to map the potential of VOM from endocardium, thereby facilitating precise endocardial mitral isthmus linear ablation. The modified stepwise approach effectively reduces the number of endocardial ablation points and the likelihood of requiring epicardial ablation. (NCT06145906, ClinicalTrial.gov).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.